+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific Ophthalmology Drugs and Devices Market 2019-2027

  • ID: 4827812
  • Report
  • Region: Asia Pacific
  • 104 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
Market Outlook

A research report by the author states that the market in Asia-Pacific for ophthalmology drugs and devices is expected to grow with a CAGR of 6.41% during the forecast period from 2019 to 2027. Japan, India, China, Australia & New Zealand, ASEAN countries, South Korea and countries in rest of APAC together form the ophthalmology drugs and devices market in the Asia-Pacific region. The ophthalmology drugs and devices market in Australia is primarily driven by government programs to improve access to comprehensive eye care services and government investments to promote eye care research. As per the Vision 2020 Australia Organization, The National Eye Health Survey (NEHS) is the first of its kind to determine the prevalence of major causes that lead to blindness and vision impairment among Australians, which has been prepared by the Center for Eye Research Australia and Vision 2020. Additionally, the plan aims to conduct researches to improve eye health that may raise the demand for ophthalmology drugs and devices, which is expected to boost the growth of the ophthalmology drugs and devices market in Australia. Furthermore, government investments to promote eye care research are also expected to drive the Australian market during the forecast period. Funding from the government would support various researches in ophthalmology, with an aim to invent advanced drugs and devices, which are expected to boost the growth of the ophthalmology drugs and devices market in Australia.

Competitive Outlook
The important players in the market are Allergan, Inc., Bayer, Carl Zeiss AG, Essilor International S.A. and GlaxoSmithKline.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
1. Asia-Pacific Ophthalmology Drugs and Devices Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Analysis
2.2.1. Bargaining Power of Buyers
2.2.2. Bargaining Power of Supplier
2.2.3. Threats of New Entrants
2.2.4. Threats of Substitutes
2.2.5. Competitive Rivalry
2.3. Strategic Outlook
2.4. Key Insight
2.5. Value Chain Outlook
2.6. Key Buying Standards
2.7. Investment Outlook
2.8. Supply Chain Outlook
2.9. Regulatory Framework
2.10. Market Drivers
2.10.1. Increasing Ophthalmic Disorders Due to High Blood Sugar
2.10.2. Upsurge in Healthcare Spending
2.10.3. Technological Advancement
2.11. Market Restraints
2.11.1. Expirations of Brand Patents Have Affected the Pharmaceutical Industry
2.11.2. Low Cognizance Related to Ophthalmic Drugs
2.11.3. Drug Approvals Delay and Number of Drugs in the Pipeline
2.12. Market Opportunities
2.12.1. Demand for Phacoemulsification Devices and Intraocular Lenses Is Increasing
2.13. Market Challenges
2.13.1. Difficulties Associated With the Conduct of Ocular Diseases

3. Ophthalmology Drugs and Devices Market Outlook - by Drugs and Devices
3.1. Devices
3.1.1. Diagnostic & Monitoring Equipment
3.1.1.1. Optical Coherence Tomography
3.1.1.2. Ophthalmic Ultrasound Imaging Systems
3.1.1.3. Fundus Camera Market
3.1.1.4. Ophthalmoscopes
3.1.1.5. Retinoscope
3.1.1.6. Pachymeter
3.1.1.7. Wavefront Aberrometers
3.1.1.8. Perimeters/Visual Field Analyzer
3.1.1.9. Autorefractors/Phoropter
3.1.1.10. Specular Microscope
3.1.1.11. Corneal Topographers
3.1.1.12. Other Diagnostic & Monitoring Equipment Market
3.1.2. Surgery Devices
3.1.2.1. Cataract Surgery Devices
3.1.2.2. Glaucoma Surgery Devices
3.1.2.3. Refractive Surgery Devices
3.1.2.4. Vitreoretinal Surgery Devices
3.1.3. Vision Care
3.2. Drugs
3.2.1. Glaucoma Drug
3.2.2. Retinal Disorder Drug
3.2.3. Dry Eye Drug
3.2.4. Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug
3.2.5. Drugs by Use of Preservation
3.2.5.1. Preserved Drugs
3.2.5.2. Preservative-Free Drugs

4. Ophthalmology Drugs and Devices Market - Regional Outlook
4.1.1. India
4.1.2. China
4.1.3. Japan
4.1.4. South Korea
4.1.5. Australia & New Zealand
4.1.6. Asean Countries
4.1.7. Rest of Apac

5. Competitive Landscape
5.1. Allergan, Inc.
5.2. Bayer
5.3. Carl Zeiss AG
5.4. Essilor International S.A.
5.5. Glaxosmithkline
5.6. Johnson & Johnson, Inc.
5.7. Novartis International AG
5.8. Pfizer
5.9. Roche Holding AG
5.10. Santen Pharmaceutical Co., Ltd.

6. Methodology and Scope
6.1. Research Scope
6.2. Sources of Data
6.3. Research Methodology

List of Tables
Table 1 Asia-Pacific Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 2 Common Causes of Loss of Vision in the Elderly
Table 3 Selected List of Glaucoma Drugs in Late-Stage Clinical Trials
Table 4 Asia-Pacific Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 5 Asia-Pacific Devices Market in Diagnostic & Monitoring Equipment by Types 2019-2027 ($ Million)
Table 6 Asia-Pacific Devices Market in Surgery Device by Types 2019-2027 ($ Million)
Table 7 Asia-Pacific Drugs and Devices Market in Drugs by Types 2019-2027 ($ Million)
Table 8 Asia-Pacific Ophthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)

List of Figures
Figure 1 Asia-Pacific Ophthalmology Drugs and Devices Market 2019-2027
Figure 2 Asia-Pacific Drugs and Devices Market in Devices 2019-2027 ($ Million)
Figure 3 Asia-Pacific Devices Market in Diagnostic & Monitoring Equipment 2019-2027 ($ Million)
Figure 4 Asia-Pacific Diagnostic & Monitoring Equipment Market in Optical Coherence Tomography 2019-2027 ($ Million)
Figure 5 Asia-Pacific Diagnostic & Monitoring Equipment Market in Ophthalmic Ultrasound Imaging Systems 2019-2027 ($ Million)
Figure 6 Asia-Pacific Diagnostic & Monitoring Equipment Market in Fundus Camera Market 2019-2027 ($ Million)
Figure 7 Asia-Pacific Diagnostic & Monitoring Equipment Market in Ophthalmoscopes 2019-2027 ($ Million)
Figure 8 Asia-Pacific Diagnostic & Monitoring Equipment Market in Retinoscope 2019-2027 ($ Million)
Figure 9 Asia-Pacific Diagnostic & Monitoring Equipment Market in Pachymeter 2019-2027 ($ Million)
Figure 10 Asia-Pacific Diagnostic & Monitoring Equipment Market in Wavefront Aberrometers 2019-2027 ($ Million)
Figure 11 Asia-Pacific Diagnostic & Monitoring Equipment Market in Perimeters/Visual Field Analyzer 2019-2027 ($ Million)
Figure 12 Asia-Pacific Diagnostic & Monitoring Equipment Market in Autorefractors/Phoropter 2019-2027 ($ Million)
Figure 13 Asia-Pacific Diagnostic & Monitoring Equipment Market in Specular Microscope 2019-2027 ($ Million)
Figure 14 Asia-Pacific Diagnostic & Monitoring Equipment Market in Corneal Topographers 2019-2027 ($ Million)
Figure 15 Asia-Pacific Diagnostic & Monitoring Equipment Market in Other Diagnostic & Monitoring Equipment Market 2019-2027 ($ Million)
Figure 16 Asia-Pacific Devices Market in Surgery Device 2019-2027 ($ Million)
Figure 17 Asia-Pacific Surgery Devices Market in Cataract Surgery Devices 2019-2027 ($ Million)
Figure 18 Asia-Pacific Surgery Devices Market in Glaucoma Surgery Devices 2019-2027 ($ Million)
Figure 19 Asia-Pacific Surgery Devices Market in Refractive Surgery Devices 2019-2027 ($ Million)
Figure 20 Asia-Pacific Surgery Devices Market in Vitreoretinal Surgery Devices 2019-2027 ($ Million)
Figure 21 Asia-Pacific Devices Market in Vision Care Market 2019-2027 ($ Million)
Figure 22 Asia-Pacific Drugs and Devices Market in Drugs 2019-2027 ($ Million)
Figure 23 Asia-Pacific Drugs Market in Glaucoma Drug 2019-2027 ($ Million)
Figure 24 Asia-Pacific Drugs Market in Retinal Disorder Drug 2019-2027 ($ Million)
Figure 25 Asia-Pacific Drugs Market in Dry Eye Drug 2019-2027 ($ Million)
Figure 26 Asia-Pacific Drugs Market in Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug 2019-2027 ($ Million)
Figure 27 Asia-Pacific Drugs by Use of Preservation in Preserved Drugs 2019-2027 ($ Million)
Figure 28 Asia-Pacific Drugs by Use of Preservation in Preservative-Free Drugs 2019-2027 ($ Million)
Figure 29 Asia-Pacific Preservative-Free Drugs Market in Single-Dose 2019-2027 ($ Million)
Figure 30 Asia-Pacific Preservative-Free Drugs Market in Multi-Dose 2019-2027 ($ Million)
Figure 31 Asia-Pacific Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 32 India Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 33 China Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 34 Japan Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 35 South Korea Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 36 Australia & New Zealand Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 37 Asean Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 38 Rest of Apac Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Essilor International S.A.
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • Pfizer
  • Roche Holding AG
  • Santen Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll